CHARLES BUTLER, M.D.
Internal Medicine Physician · COLUMBIA, SC
Individual Active NPI 1881725364
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,445 | 334,827 | $17,956,398 | $7,693,385 | $6,142,499 |
| 2023 | 1,206 | 361,300 | $17,842,360 | $7,069,271 | $5,637,834 |
| 2022 | 1,255 | 360,472 | $15,757,455 | $6,150,096 | $4,902,280 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 63,750 | $1 | $1 |
| J9271 | Injection, pembrolizumab, 1 mg | 31,400 | $56 | $44 |
| J9299 | Injection, nivolumab, 1 mg | 21,960 | $31 | $25 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 19,800 | $0 | $0 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 14,550 | $3 | $2 |
| J0897 | Injection, denosumab, 1 mg | 13,800 | $25 | $20 |
| J0185 | Injection, aprepitant, 1 mg | 11,180 | $2 | $1 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 11,160 | $49 | $39 |
| J9155 | Injection, degarelix, 1 mg | 8,720 | $4 | $3 |
| J1930 | Injection, lanreotide, 1 mg | 7,680 | $46 | $37 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 6,996 | $27 | $21 |
| J1627 | Injection, granisetron, extended-release, 0.1 mg | 6,100 | $5 | $4 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Internal Medicine Physician | 207R00000X | ✓ | LL 29016 | SC |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Internal Medicine Physician providers in South Carolina
- NPI 1205165792
- NPI 1013089572
- NPI 1629164876
- NPI 1295430627
- NPI 1720048978
- NPI 1770543621
- NPI 1447435003
- NPI 1326743766
See all Internal Medicine Physician providers in South Carolina →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.